An exceptional case of full-thickness macular hole closure in a patient with Behçet disease.
OBJECTIVE
To present a case of a full-thickness macular hole closure in a patient with Behcet uveitis.


METHODS
A 23-year-old-male patient with Behcet Disease had clinically inactive uveitis with topical steroids, oral azathiopurine and cyclosporine until he developed a retinal infiltrate in the left eye which evolved into a full-thickness macular hole during the follow-up.


METHODS
Strict control of inflammation and subsequent vitrectomy was planned. Meanwhile another attack of panuveitis developed in the left eye and subcutaneous Interferon alfa-2b interferon treatment was initiated.


RESULTS
After 2 months, the patient was clinically inactive with complete closure of the macular hole.


CONCLUSIONS
Strict control of inflammation may result in closure of the macular hole and avoid the need for vitrectomy.
Ophthalmology Department, Istanbul University Cerrahpasa Medical Faculty , Istanbul , Turkey .
Didar
D
Uçar
Eray
E
Atalay
Yilmaz
Y
Özyazgan
Ahmet
A
Özkök
Yeliz
Y
Yıldırım
D000284:Administration, Oral; D000287:Administration, Topical; D001379:Azathioprine; D001528:Behcet Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D015864:Panuveitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D011994:Recombinant Proteins / Q000627:therapeutic use; D012075:Remission, Spontaneous; D012167:Retinal Perforations / Q000209:etiology / Q000503:physiopathology*; D041623:Tomography, Optical Coherence; D014792:Visual Acuity / Q000502:physiology; D055815:Young Adult
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D016572:Cyclosporine; D001379:Azathioprine